Connection
Christine Walsh to Molecular Targeted Therapy
This is a "connection" page, showing publications Christine Walsh has written about Molecular Targeted Therapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.223 |
|
|
|
-
Walsh C. Targeted therapy for ovarian cancer: the rapidly evolving landscape of PARP inhibitor use. Minerva Ginecol. 2018 Apr; 70(2):150-170.
Score: 0.122
-
Walsh CS. Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy. Gynecol Oncol. 2015 May; 137(2):343-50.
Score: 0.101